Alyeska Investment Group
WINT

Alyeska Investment Group’s Windtree Therapeutics Inc WINT Stock Holding History

Alyeska Investment Group’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-459,364
Closed -$524K – 620
2017
Q1 		$524K Sell
459,364
-5,405
-1% -$7.02K ﹤0.01% 450
2016
Q4 		$581K Buy
464,769
+3,703
+0.8% +$6.84K ﹤0.01% 443
2016
Q3 		$1.18M Sell
461,066
-3,175
-0.7% -$6.91K 0.01% 408
2016
Q2 		$896K Buy
464,241
+9,420
+2% +$22.8K 0.01% 391
2016
Q1 		$760K Buy
454,821
+12,858
+3% +$27.6K 0.01% 360
2015
Q4 		$1.32M Buy
441,963
+166,355
+60% +$682K 0.01% 326
2015
Q3 		$1.16M Buy
275,608
+196,886
+250% +$1.3M 0.01% 380
2015
Q2 		$749K Sell
78,722
-20,670
-21% -$290K 0.01% 427
2015
Q1 		$1.66M Sell
99,392
-22,416
-18% -$441K 0.02% 388
2014
Q4 		$1.98M Sell
121,808
-11,654
-9% -$256K 0.03% 339
2014
Q3 		$3.44M Sell
133,462
-6,312
-5% -$152K 0.07% 257
2014
Q2 		$3.48M Buy
139,774
+10,504
+8% +$269K 0.08% 267
2014
Q1 		$3.89M Buy
129,270
+38,999
+43% +$1.31M 0.11% 221
2013
Q4 		$2.84M Buy
90,271
+42,857
+90% +$1.34M 0.11% 210
2013
Q3 		$1.3M Buy
47,414
+271
+0.6% +$6.57K 0.05% 250
2013
Q2 		$1M Buy
+47,143
New +$1.16M 0.05% 240

Other funds holding WINT

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Alyeska Investment Group's WINT Position: Q2 2017 in Review

Alyeska Investment Group sold out of Windtree Therapeutics Inc (WINT) in Q2 2017, closing a stake of 459,364 shares — an estimated $524K sold.

Alyeska Investment Group first reported a position in WINT in Q2 2013 and held it in 16 quarters. The position peaked at $3.89M in Q1 2014. 3 funds tracked by Wall St. Rank hold WINT as of Q2 2017.

  • Alyeska Investment Group reported no remaining Windtree Therapeutics Inc position as of Q2 2017 after selling out during the quarter.
  • Alyeska Investment Group sold 459,364 Windtree Therapeutics Inc shares in Q2 2017, an estimated $524K.
  • Alyeska Investment Group first reported a position in Windtree Therapeutics Inc in Q2 2013 and held it in 16 quarters.
  • Alyeska Investment Group's Windtree Therapeutics Inc position peaked at $3.89M in Q1 2014.
  • 3 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q2 2017.

Based on Alyeska Investment Group's 13F filing for Q2 2017, filed 14 Aug 2017.